Virtus LifeSci Biotech Products ETF Rating $69.65 -0.74 (-1.05%) Closing price 09/19/2025 04:10 PM EasternExtended Trading$70.03 +0.38 (+0.55%) As of 09/19/2025 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.84Holdings in BBP have an aggregate rating of Moderate Buy based on 299 analyst ratings issued in the past year covering 25 companies (55.4% of the portfolio).BBP Aggregate Price Target$69.65High Prediction$69.65Average Prediction$69.65Low Prediction$69.65Holdings in BBP have an aggregate price target of $69.65 and a range of $69.65 to $69.65 covering 25 companies (55.4% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy11 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold3 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.83%ARDXArdelyx$6.21-3.3%4.3827 of 5 stars3.10$11.70 88.4%10Positive News2.83%IONSIonis Pharmaceuticals$61.01-1.2%3.9198 of 5 stars2.81$67.88 11.3%16Insider TradeAnalyst Revision2.64%TVTXTravere Therapeutics$24.85+2.7%2.8077 of 5 stars2.87$34.20 37.6%15Analyst Forecast2.45%RYTMRhythm Pharmaceuticals$96.06-2.5%3.2567 of 5 stars3.07$101.57 5.7%15Positive NewsHigh Trading Volume2.45%AUPHAurinia Pharmaceuticals$13.00+0.9%2.5033 of 5 stars3.00$13.00 0.0%22.44%MIRMMirum Pharmaceuticals$74.38-1.2%3.3152 of 5 stars3.11$74.44 0.1%9High Trading Volume2.42%ALNYAlnylam Pharmaceuticals$453.56+0.3%3.8643 of 5 stars2.86$439.58 -3.1%28Trending NewsAnalyst Forecast2.37%INSMInsmed$144.76-0.8%3.0521 of 5 stars2.94$139.86 -3.4%17High Trading Volume2.33%MDGLMadrigal Pharmaceuticals$439.93-0.2%3.9584 of 5 stars2.90$483.38 9.9%10High Trading Volume2.30%LGNDLigand Pharmaceuticals$166.51-2.0%4.2324 of 5 stars3.00$176.50 6.0%6News CoveragePositive NewsHigh Trading Volume2.24%HALOHalozyme Therapeutics$77.81+1.5%4.5637 of 5 stars2.33$67.11 -13.8%12News CoveragePositive NewsHigh Trading Volume2.23%UTHRUnited Therapeutics$417.57+1.9%4.6473 of 5 stars2.69$438.85 5.1%13Trending NewsInsider TradeHigh Trading Volume2.13%CRSPCRISPR Therapeutics$62.32-1.0%2.937 of 5 stars2.50$71.50 14.7%18News CoverageAnalyst ForecastHigh Trading Volume2.10%KNSAKiniksa Pharmaceuticals International$35.42-1.4%2.6984 of 5 stars3.00$41.17 16.2%6Positive NewsInsider TradeShort Interest ↑2.09%BBIOBridgeBio Pharma$52.37-1.8%4.3258 of 5 stars3.00$63.94 22.1%17High Trading Volume2.08%APLSApellis Pharmaceuticals$23.01-1.6%4.1189 of 5 stars2.58$34.12 48.3%19Trending NewsInsider TradeAnalyst Revision2.05%FOLDAmicus Therapeutics$8.33-1.8%3.9481 of 5 stars2.89$15.78 89.4%9News CoverageAnalyst UpgradeHigh Trading Volume2.03%TBPHTheravance Biopharma$13.88-4.1%3.3282 of 5 stars3.20$23.00 65.7%5Short Interest ↑1.99%TARSTarsus Pharmaceuticals$55.00+1.8%1.9411 of 5 stars2.71$66.67 21.2%7Positive NewsHigh Trading Volume1.98%ROIVRoivant Sciences$15.04-0.3%3.4462 of 5 stars3.00$19.94 32.6%9Trending NewsAnalyst ForecastAnalyst Revision1.96%INCYIncyte$86.53+0.6%4.7679 of 5 stars2.33$82.53 -4.6%18Trending NewsAnalyst ForecastShort Interest ↓High Trading Volume1.91%ONCBeOne Medicines$334.40-2.5%1.8882 of 5 stars3.11$336.30 0.6%9News CoverageAnalyst ForecastInsider TradeGap Down1.89%PHATPhathom Pharmaceuticals$11.21-4.6%2.4835 of 5 stars3.00$17.50 56.1%61.88%PTCTPTC Therapeutics$60.48-3.8%3.8744 of 5 stars2.53$69.00 14.1%15Insider Trade1.82%NVAXNovavax$8.71+2.1%4.2083 of 5 stars2.13$14.29 64.0%8 This page (NYSEARCA:BBP) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.